Target intelligence / Profile preview

MARK2 pseudogene 14 (MARK2P14)

Target
MARK2P14
Molecular classification
Other, Pseudogene
01

Overview

MARK2 pseudogene 14 (MARK2P14) is a processed or unprocessed fragment in the human genome with high sequence similarity to MARK2, but it does not encode a functional protein. Like most pseudogenes, it is not considered a therapeutic target, does not encode receptor, enzyme, or transporter activity, and is not involved in signal transduction, cell cycle regulation, or known disease processes. While certain pseudogenes can play regulatory roles in transcriptomic networks, there is no evidence that MARK2P14 has such a function. The core MARK2 gene, by contrast, is a serine/threonine kinase regulating cell polarity and microtubule dynamics.

Other names
MAP/microtubule affinity-regulating kinase 2 pseudogene 14microtubule affinity regulating kinase 2 pseudogene 14MARK2P14
02

Mechanism of action

None; pseudogenes do not produce functional proteins or serve as direct drug targets

03

Biological functions

Possible regulatory role in gene expression through pseudogene mechanisms such as acting as a competitive endogenous RNA (ceRNA), but no direct protein-coding or enzymatic/regulatory activity
04

Disease associations

None established for this specific pseudogene; no direct disease relevance currently documented. The parent gene MARK2 is tied to neurological disorders and cell polarity, but not the pseudogene itself

Beyond the preview

Go deeper on MARK2 pseudogene 14 (MARK2P14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MARK2 pseudogene 14 (MARK2P14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call